Table 7.
Banff scores in the first and second surveillance biopsies in patients with and without IF/TA progression between biopsies.
| Variable | No Progression | IFTA Progression | p-Value |
|---|---|---|---|
| (n = 50) | (n = 35) | ||
| g+ptc score 1st biopsy | 0.32 ± 0.74 | 0.14 ± 0.43 | 0.207 |
| i+t score 1st biopsy | 0.56 ± 0.91 | 0.29 ± 0.62 | 0.125 |
| i-IFTA score 1st biopsy | 1.43 ± 1.19 | 1.03 ± 1.12 | 0.124 |
| ci+ct score 1st biopsy | 1.90 ± 1.27 | 0.89 ± 0.93 | 0.001 |
| ah-score 1st biopsy | 0.40 ± 0.61 | 0.34 ± 0.69 | 0.686 |
| g+ptc score 2nd biopsy | 0.24± 0.56 | 0.46 ± 0.95 | 0.188 |
| i+t score 2nd biopsy | 0.48 ± 0.89 | 0.46 ± 0.70 | 0.899 |
| ci+ct score 2nd biopsy | 1.60 ± 1.28 | 2.71 ± 1.64 | 0.001 |
| i-IFTA score 2nd biopsy | 1.20 ± 1.27 | 1.69 ± 1.08 | 0.073 |
| ah-score 2nd biopsy | 0.69 ± 0.77 | 0.60 ± 0.85 | 0.598 |
g, glomerulitis; ptc, peritubular capillaritis; i, interstitial inflammation in non-scarred cortex; t, tubulitis; ci, interstitial fibrosis; ct, tubular atrophy; i-total, interstitial inflammation in the whole cortex; i-IFTA, interstitial inflammation in scarred cortex; ah, arteriolar hyalinosis.